Back to EPRX
UBS Group AG EPRX Position History
Eupraxia Pharmaceuticals Inc. • Healthcare
Quarters held
16
Latest value
$22K
Q3 2026
Peak value
$5.2M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $215K |
| Q3 2025 | $348K |
| Q3 2025 | $2K |
| Q4 2025 | $276K |
| Q4 2025 | $1.4M |
| Q4 2025 | $189 |
| Q1 2026 | $257K |
| Q1 2026 | $5.2M |
| Q1 2026 | $36K |
| Q2 2026 | $235K |
| Q2 2026 | $2.4M |
| Q2 2026 | $746K |
| Q2 2026 | $35K |
| Q3 2026 | $323K |
| Q3 2026 | $2.1M |
| Q3 2026 | $22K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $22K | 2.5K | — | — |
| Q3 2026 | $2.1M | 232.2K | — | — |
| Q3 2026 | $323K | 35.5K | — | — |
| Q2 2026 | $35K | 5.3K | — | — |
| Q2 2026 | $746K | 112.9K | — | — |
| Q2 2026 | $2.4M | 365.5K | — | — |
| Q2 2026 | $235K | 35.5K | — | — |
| Q1 2026 | $36K | 4.9K | — | — |
| Q1 2026 | $5.2M | 722.2K | — | — |
| Q1 2026 | $257K | 35.5K | — | — |
| Q4 2025 | $189 | 25 | — | — |
| Q4 2025 | $1.4M | 183.5K | — | — |
| Q4 2025 | $276K | 36.5K | — | — |
| Q3 2025 | $2K | 356 | — | — |
| Q3 2025 | $348K | 58.9K | — | — |
| Q3 2025 | $215K | 36.5K | — | — |